Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
Journal
Blood cancer discovery
ISSN: 2643-3249
Titre abrégé: Blood Cancer Discov
Pays: United States
ID NLM: 101764786
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
02
06
2021
revised:
29
07
2021
accepted:
01
11
2021
entrez:
12
1
2022
pubmed:
13
1
2022
medline:
6
5
2022
Statut:
ppublish
Résumé
We assessed minimal residual disease (MRD) detection and B-cell aplasia after tisagenlecleucel therapy for acute lymphoblastic leukemia (ALL) to define biomarkers predictive of relapse (
Identifiants
pubmed: 35019853
pii: 2643-3230.BCD-21-0095
doi: 10.1158/2643-3230.BCD-21-0095
pmc: PMC9924295
doi:
Substances chimiques
Antigens, CD19
0
Receptors, Antigen, T-Cell
0
tisagenlecleucel
Q6C9WHR03O
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
66-81Subventions
Organisme : NHLBI NIH HHS
ID : T32 HL007950
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
©2021 The Authors; Published by the American Association for Cancer Research.
Références
BMC Cancer. 2020 Jun 30;20(1):612
pubmed: 32605647
Blood. 2017 Jun 22;129(25):3322-3331
pubmed: 28408462
Blood. 2018 Mar 22;131(12):1350-1359
pubmed: 29284596
Blood. 2012 Dec 20;120(26):5173-80
pubmed: 23074282
J Clin Oncol. 2015 Apr 10;33(11):1275-84
pubmed: 25605857
Blood. 2014 Mar 27;123(13):2017-25
pubmed: 24497539
J Clin Oncol. 2008 Jun 20;26(18):3046-50
pubmed: 18565891
Leukemia. 2021 Dec;35(12):3383-3393
pubmed: 34002027
N Engl J Med. 2013 Apr 18;368(16):1509-1518
pubmed: 23527958
Cancer Discov. 2015 Dec;5(12):1282-95
pubmed: 26516065
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Leukemia. 2018 Nov;32(11):2316-2325
pubmed: 29728694
J Clin Oncol. 2021 Mar 10;39(8):920-930
pubmed: 33417474
Blood Adv. 2020 May 26;4(10):2325-2338
pubmed: 32453841
N Engl J Med. 2014 Oct 16;371(16):1507-17
pubmed: 25317870
Clin Cancer Res. 2018 Dec 15;24(24):6175-6184
pubmed: 30190371
Blood. 2019 Apr 11;133(15):1652-1663
pubmed: 30728140
Blood Adv. 2019 Nov 12;3(21):3393-3405
pubmed: 31714961
Blood. 2010 Apr 22;115(16):3206-14
pubmed: 20154213
Nat Med. 2018 Oct;24(10):1504-1506
pubmed: 30275569
J Clin Oncol. 2021 May 20;39(15):1650-1659
pubmed: 33764809
Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S71-4
pubmed: 18545248
Blood. 2015 Aug 20;126(8):964-71
pubmed: 26124497
Blood. 2015 May 28;125(22):3501-8
pubmed: 25862561
J Clin Oncol. 2009 Jan 20;27(3):377-84
pubmed: 19064980